Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-17 of 17 for your search:
Cancer Type:
Brain tumor, adult: General and other
Stage/Subtype of Cancer:
craniopharyngioma, adult
Country:
U.S.A.
Trial Type:
Treatment
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
A Phase I/II Study of the Photon Radiosurgery System
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
2 to 32
Sponsor:
Other
Protocol IDs:
CNS 0201
, NCT00179907
2.
Intracerebral Clysis in Treating Patients With Recurrent Primary Brain Tumors
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
1 to 120
Sponsor:
Other
Protocol IDs:
R01 CA 89395-01
, Topotecan, Brain Tumors, Intracerebral Clysis, NCT00452959
3.
Antineoplaston Therapy in Treating Patients With Brain Tumors
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
BC-BT-9
, NCT00003457
4.
Exploratory Study, Evaluating the Treatment Effect of Surgery Plus GLIADELĀ® Wafer in Patients With Metastatic Brain Cancer
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
GLIA-001
, NCT00525590
5.
Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
Not specified
Sponsor:
Other
Protocol IDs:
3368
, NCT00576537
6.
Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
3 to 70
Sponsor:
Other
Protocol IDs:
MCW-7594
, MCW-CHW-511, MCW-CHW-9411, NCI-V95-0652, NCT00002647
7.
Melphalan and Mannitol in Treating Patients With Central Nervous System Cancer
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
18 months and over
Sponsor:
NCI
Protocol IDs:
OHSU-1299
, OHSU-ONC-98018-L, OHSU-4834, NCT00253721
8.
A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer Patients
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
05C.255
, NCT00329589
9.
Phase I Study Using Sunitinib Plus Radiation Therapy for Cancer Patients
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
06C.549
, NCT00437372
10.
Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
45 and under
Sponsor:
Other
Protocol IDs:
2004-0079
, NCT00502892
11.
Valproate and Etoposide for Patients With Neuronal Tumors and Brain Metastases
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
Any age
Sponsor:
Other
Protocol IDs:
2007-0370
, NCT00513162
12.
Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
CHNMC-04032
, 04032, NCT00544284
13.
Bone Marrow Radiation Therapy Followed by Busulfan, Melphalan, Thiotepa, and an Autologous Stem Cell Transplant in Treating Patients With High-Risk or Relapsed Solid Tumors
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Diagnostic, Treatment
Status:
Active
Age:
70 and under
Sponsor:
NCI
Protocol IDs:
UMN-2005LS023
, UMN-2005LS023, UMN-MT2004-30, NCT00623077
14.
Combination of Sorafenib and Radiation for Brain Metastases and Primary Brain Tumors
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
07C.381
, NCT00639262
15.
Temsirolimus With or Without Temozolomide in Treating Patients With Primary or Metastatic Brain Tumors
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
CHNMC-07064
, 07064, NCT00784914
16.
Determination of Fraction Size Equivalent Dose (FED) Levels for Intracranial Conformal Avoidance Radiotherapy
Phase:
No phase specified
Type:
Diagnostic, Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI, Other
Protocol IDs:
RO04323
, NCI-P01 CA88960, NCT00214175
17.
Magnetic Resonance Temperature Imaging & Imaging-Guided Laser Induced Thermal Therapy for Treatment of Metastatic Brain Tumors
Phase:
No phase specified
Type:
Treatment
Status:
Active
Age:
Not specified
Sponsor:
Other
Protocol IDs:
2007-0610
, NCT00720837
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute